Linda Horton and Crystal Liu describe the Food and Drug Administration’s proposed pilot programme and discuss concerns raised by industry.
The US Food and Drug Administration has received numerous industry comments on its proposal, announced earlier this year, to run a voluntary secure supply chain pilot programme aimed at increasing the safety of imported finished pharmaceutical products and active pharmaceutical ingredients1...
Please login to read the full article.
